Casirivimab/imdevimab appeared to lower the incidence of symptomatic COVID-19 in an infected, but asymptomatic, group. Editorialists urge caution, however, in interpreting the results.
Medscape Medical News
…read more
Casirivimab/imdevimab appeared to lower the incidence of symptomatic COVID-19 in an infected, but asymptomatic, group. Editorialists urge caution, however, in interpreting the results.
Medscape Medical News
…read more